Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Crescita Therapeutics Inc CRRTF


Primary Symbol: T.CTX

Healthcare
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial... see more

Recent & Breaking News (TSX:CTX)

Crescita Reports Third Quarter 2024 Results

Business Wire November 6, 2024

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Business Wire September 24, 2024

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Business Wire September 12, 2024

Crescita Reports Second Quarter 2024 Results

Business Wire August 7, 2024

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Business Wire July 22, 2024

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Business Wire July 19, 2024

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device

Business Wire July 17, 2024

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Business Wire June 26, 2024

Crescita to Acquire Strategic Assets of Occy Laboratory

Business Wire June 20, 2024

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Business Wire June 6, 2024

Crescita Reports First Quarter 2024 Results

Business Wire May 8, 2024

Crescita Reports Q4 and Fiscal 2023 Results

Business Wire March 13, 2024

Crescita Reports Third Quarter 2023 Results

Business Wire November 8, 2023

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Business Wire August 29, 2023

Crescita Reports Second Quarter 2023 Results

Business Wire August 9, 2023

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Business Wire June 21, 2023

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

PR Newswire June 1, 2023

Crescita Reports First Quarter 2023 Results

Business Wire May 11, 2023

Crescita Reports Q4 and Fiscal 2022 Results

Business Wire March 15, 2023

Crescita Reports Third Quarter 2022 Results

Business Wire November 9, 2022